Karmela Krleza-Jeric
Resume
Karmela Krleža-Jerić, MD, M.Sc, D.Sc.
karmela.krleza-jeric@mefst.hr / Karmela@krleza.com
ORCID: orcid.org/0000-0001-9377-0917
Dr. Krleža-Jerić is a strong advocate of transparency of health research, especially of open access to clinical trial data and she promotes the development of ethical and other related standards to support these goals. Karmela graduated medicine at the University of Sarajevo, and completed her masters and doctoral studies at the University of Zagreb, Croatia.
Karmela is the one of co-founders and a leader of the
She spent ten years (2002-2012) at the Canadian Institute of Health Research where she mainly worked on clinical research and its transparency, including participation in creation of the International standards for trial registration as a member of the WHO Scientific Advisory Group, leading an analysis of transparency of clinical trials in the Americas, OG recommendations for the 7th revision of the Declaration of Helsinki and comments on the NIH Expansion of the Clinical Trial Registry and Results Data Bank. At the time she was also a Regional Editor of the Croatian Medical Journal, and an Adjunct Professor at the University of Ottawa.
She is a member of the ISRCTN Advisory Group, SPIRIT working group, Cochrane Consumers' Network, Campbell and Cochrane Equity, Bias Methods, and PRISMA IPD groups.
Over the years, Karmela has acted as a consultant to the World Health Organisation (WHO) on health planning, health economics, the HFA (Health for all by the year 2000), Healthy Cities, and clinical trials.
Karmela works on the IMPACT Observatory as a NEWFELPRO, Marie Sklodowska-Curie and Croatian Government, Fellow at the Split University School of Medicine, Split, Croatia.